Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalypsis in Advanced Ewing Family of Tumors
NCT01222767Phase 2Completed
- Sponsor
- PharmaMar
- Start
- Dec 2010
- Primary completion
- Apr 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of zalypsis in Ewing sarcoma, sponsored by PharmaMar. Started Dec 2010; status: completed.
02
Drugs
zalypsis
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT01222767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222767.